Daan Gene has obtained a medical device registration certificate from the National Medical Products Administration for its Hepatitis B Virus Nucleic Acid Detection Kit (Fluorescent PCR Method), valid until July 15, 2031. The kit is used for in vitro quantitative detection of hepatitis B virus deoxyribonucleic acid content in human serum or plasma samples. The acquisition of this registration certificate enriches the company's product portfolio and broadens the application areas of its products. In the first quarter of 2026, Daan Gene achieved revenue of 149 million yuan and a net loss attributable to the parent company of 98.15 million yuan.
Da An Gene Co Ltd of Sun Yat-Sen UniversityObtained medical device registration certificate for Hepatitis B Virus Nucleic Acid Detection Kit, expanding product portfolio and application areas.